Literature DB >> 3840055

Analgesia and autonomic function following intrathecal administration of morphine and norepinephrine to the rat.

C W Loomis, F W Cervenko, K Jhamandas, M Sutak, B Milne.   

Abstract

The acute intrathecal (i.t.) administration of 10, 25, 50, and 100 microgram morphine and 7.5, 10, 15, and 30 microgram (-)norepinephrine (NE) to the rat produced dose-dependent, long-lasting analgesia as assessed by the tail-flick and hot-plate tests. For i.t. morphine, maximum analgesia was observed 30-60 min after drug administration. The duration of analgesia in the tail-flick test ranged from 30 to 150 min; the duration of analgesia in the hot-plate test ranged from 60 to 120 min. For i.t. NE, maximum analgesia was observed 15-60 min after drug infusion. The duration of NE-induced analgesia in the hot-plate test ranged from 45 to 120 min and was 120 min in the tail-flick test. The effects of acute i.t. and intravenous (i.v.) infusions of morphine (10 microgram) and NE (15 microgram) on heart rate, blood pressure, arterial pH, partial pressure of oxygen (Po2), partial pressure of carbon dioxide (Pco2), and standard bicarbonate were determined over 45 min in rats anesthetized with alpha-chloralose (70 mg/kg). Morphine significantly decreased Po2 throughout the experiment but did not affect blood pressure, heart rate, pH, Pco2 and standard bicarbonate. A significant increase in blood pressure (137% of control) was observed 2.5 min after i.t. administration of NE. Intravenous NE produced a marked increase in blood pressure (246% of control) followed by a compensatory decrease in heart rate. There were no significant changes in blood gases with i.t. and i.v. NE. The data suggest that i.t. morphine and NE can produce effective analgesia with minimal effects on cardiovascular and respiratory function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840055     DOI: 10.1139/y85-109

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.

Authors:  B Milne; M Sutak; C M Cahill; K Jhamandas
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

2.  Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.

Authors:  M Hong; M Sutak; K Jhamandas
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance.

Authors:  K J Powell; A Hosokawa; A Bell; M Sutak; B Milne; R Quirion; K Jhamandas
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.

Authors:  C Gouardères; K Jhamandas; M Sutak; J M Zajac
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

5.  Enhanced immune sensitivity to stress following chronic morphine exposure.

Authors:  Kimberly A Ballard; Trisha C Pellegrino; Norma C Alonzo; Alexandria L Nugent; Barbara M Bayer
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

6.  Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects.

Authors:  Laura S Stone; Jonathan P German; Kelly F Kitto; Carolyn A Fairbanks; George L Wilcox
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.